DOI:
10.1055/s-00000175
Arzneimittelforschung
LinksClose Window
References
Shinohara Y, Katayama Y, Uchiyama S et al.,
CSPS 2 group. Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial.
Lancet Neurol 2010;
9: 959-968
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.